English
Jean Hoffman-Censits
49 posts
Jean Hoffman-Censits
@JCensits
GU oncologist - bladder, UTUC, women’s bladder and small cell special interests. Mama Bear, lover of family, nature, travel. Foodie
Maryland, USA Entrou em Ağustos 2015
565 Seguindo569 Seguidores
This week we celebrated my 2-year research fellowship at @hopkinskimmel and my residency match into @OslerResidency.
Big thank you to all those who supported me and believed in me and most of all to my mentor @JCensits. This would have never been possible without you!
English
Watch out for superstar mentee @elina_vlachou with @Ron_cology with one of her posters at GU ASCO!
English
@BladderCancerUS 2023 Baltimore BCAN walk raising awareness and supporting advocacy today and everyday @JHBladderCancer
English
A few human and furry members of the @JHBladderCancer team raising awareness for bladder cancer and UTUC this morning in Baltimore @MaxKates @djmcconkey @SHPatelMD1 @elina_vlachou
English
@elina_vlachou @hopkinskimmel @JHBladderCancer Folks watch out for this superstar!! So lucky to have you on the team!!
English
Grateful for the opportunity to show our work on “EV-related skin toxicity and response” and be selected for an Honorable Mention at @hopkinskimmel Trainee Research Day!
A big thank you to @JCensits and the entire @JHBladderCancer family for their continued support!!
English
Jean Hoffman-Censits retweetou
Congratulations #VitalyMargulis, recipient of the #SwansonAward given to a notable uro-onc @MDAndersonNews alum — stories w @cgwoodMD & launching his work in upper tract UC, now w @eaonc trial open across the country. #CHW23
@UTSWUrology @utswcancer @BladderCancerUS
English
Thank you to @FaltasLab and @urotoday for highlighting our hypothesis generating work evaluating enfortumab related skin toxicity and response in urothelial CA
UroToday.com@urotoday
Cutaneous toxicity and response to enfortumab vedotin in #UrothelialCancer patients. #ExpertCommentary with @FaltasLab @WCMEnglanderIPM discussing work from Vlachou et al. in @EurUrolOpen > bit.ly/40tygXG @elina_vlachou @JCensits @brady_urology @Andres_Matoso
English
@montypal @onepeloton @BradMcG04 @DanaFarber @DrChoueiri @PanMass @ASCO @BrainTumorDoc @ndenduluri1 @neerajaiims @PGrivasMDPhD @SuzanneColeMD @rodrocconi @GlopesMd @TiansterZhang @cityofhope @cityofhopeoc @KidneyCancer @kidneycan Welcome to the club- tons of GU representation! Sisterplatin107
English
1st @onepeloton ride ever for me, guided by @BradMcG04 @DanaFarber. Intense experience - if I keep at this, maybe I’ll join him & @DrChoueiri in @PanMass! Great way to start an early day at @ASCO HQ! @BrainTumorDoc @ndenduluri1
English
Excited to share our hypothesis generating work on Enfortumab Vedotin and cutaneous toxicity @JHBladderCancer @djmcconkey @elina_vlachou @Andres_Matoso, and add to the mounting work in the field @LisaZabaMD @sandysrimd authors.elsevier.com/sd/article/S26…
English
Jean Hoffman-Censits retweetou
Inspired educational programs for patients & families from Greenberg #Bladdercancer Institute @HopkinsMedicine @brady_urology @hopkinskimmel
English
English
English
Happy to share our comprehensive review on Enfortumab Vedotin. @JHBladderCancer @hopkinskimmel
Targeted Treatment of Locally Advanced and Metastatic Urothelial Cancer: Enfortumab Vedotin in Context pubmed.ncbi.nlm.nih.gov/36545447/
English
Thanks Dr San Chang @UroCancerMD and the team at UroToday for highlighting the care of patients with Upper Tract Urothelial Cancer and the importance of multidisciplinary care @SurenaMatinMD and Jonathan Coleman MD
UroToday.com@urotoday
A multidisciplinary approach to treating high-grade upper tract disease - A case-based approach. @SurenaMatinMD @MDAndersonNews, Jonathan Coleman, MD @MSKCancerCenter, and @JCensits @hopkinskimmel join @UroCancerMD in a case-based discussion on UroToday > bit.ly/3SaDqCX
English
English
@CharuAggarwalMD @PennCancer @PennMedicine @onepeloton @PennMDForum @Ron_cology @lynn_schuchter @ASCO @PC3Innovation @PennPrecisMed @LovaSunMD @MMarmarelis @PennMedNews Congrats to David - amazing doc and scholar! AND peloton pal? Please pass along my congrats from sisterplatin107 😂
English
Amazing celebration tonight @PennCancer as we toasted to Dr. David Vaughan’s book launch “Discovery and Healing” - 5 decades of hematology/oncology @PennMedicine - and I got a signed copy - that reads “to my @onepeloton pal:)” Cheers to David!
📕🥂🎉
English
@shilpaonc @AlisonBirtle @PGrivasMDPhD @GreatDebatesCME So lovely to be a part - what a fantastic urothelial session- thanks to the organizers!
English
Amazing debate and discussion on neoadjuvant vs adjuvant tx in localized upper tract UC by @JCensits @AlisonBirtle chaired by @PGrivasMDPhD on @GreatDebatesCME
English
@ETUroOnc @EinsteinHealth @EinsteinUrology @JEFFUrology @KimmelCancerCtr Congratulations Ed! So thrilled for you and excited to hear about the great things to come for you at Einstein!
English
So excited to join @EinsteinHealth @EinsteinUrology tomorrow as Chair! Bittersweet but exciting new challenge leaving from @JEFFUrology @KimmelCancerCtr
English
@MaxKates @SimaPorten @FaltasLab Yes wondering when the folks at O’Hare will start charging me room and board. hoping to see everyone soon
English
Finally in the air en route to #BCANTT22 after major flight delays. Can't wait to see this amazing program lead by @SimaPorten @FaltasLab in action.
English
Now enrolling- a trial of chemo and immunotherapy for patients with small cell bladder cancer prior to surgery
Johns Hopkins Kimmel Cancer Center@hopkinskimmel
Researchers @hopkinskimmel are conducting an immunotherapy+chemotherapy study for patients with localized invasive small cell #bladdercancer. For more information, including how to find out if you are eligible for the Small Cell Bladder Cancer Trial, visit clinicaltrials.gov/ct2/show/NCT05…
English
@allaf_mo @SHPatelMD1 @brady_urology Congratulations Sunil! We are so fortunate to have you!! Looking forward to watching your stellar career!
English
Another warm welcome to Dr. Sunil Patel @SHPatelMD1 joining @brady_urology in July as Associate Program Director of the Residency and member of our urologic oncology division. Welcome Dr. Patel.
English